COMPANY
RHYTHM PHARMACEUTICALS, INC.
RHYTHM PHARMACEUTICALS, INC.: marketing authorisation holder, US labeler, trial sponsor for Setmelanotide, as stated by public registers.
Also written as: Rhythm Pharmaceuticals, Inc; Rhythm Pharmaceuticals Inc.; Rhythm Pharmaceuticals, Inc..
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Setmelanotide | IMCIVREE (DIN 02537745), Marketed Regulator Health Canada |
|---|
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Setmelanotide | Imcivree, NDA Regulator openFDA |
|---|
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Setmelanotide | 1 registered trial Trial register EU CTIS |
|---|---|
| Setmelanotide | 21 registered trials Trial register ClinicalTrials.gov |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.